HMD 4.35% 2.2¢ heramed limited

Hmmm, more waffle, but its in depth now.. TCG Further...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 8,334 Posts.
    lightbulb Created with Sketch. 238
    Hmmm, more waffle, but its in depth now..

    TCG

    Further information regarding Strategic Partnership – US employee rewards platform
    HeraMED Limited (ASX:HMD) (“HeraMED” or the “Company”, a medical data and technology company
    leading the digital transformation of maternity care, provides further information in relation to its
    announcement made on 1 June 2023 titled ‘Strategic Partnership signed – US employee rewards platform’.
    HeraMED is not able to provide specific financial information or forecasts in relation to the Strategic
    Partnership. Whilst Fond and Entrustia Health will proactively promote and market the HeraCARE solution to
    its customers, HeraMED can’t guarantee that material revenue will arise as it depends on the customer
    uptake. HeraMED will update the market regularly with key measures of success related to this Strategic
    Partnership, in its Quarterly reviews.

    The Fond agreement:
    • is not subject to any condition’s precedent; and
    • has an initial term of 12 months and shall automatically renew for each successive month unless
    one party provides written notice to the other at least thirty (30) days in advance that it does not
    wish to renew the following month.

    The Entrustia agreement:
    • is not subject to any condition’s precedent; and
    • has an initial term of three years to 16 May 2026 and the agreement shall automatically extend for
    subsequent terms of 12 months unless HeraMED wishes to terminate the agreement by written
    notice within 30 days of the expiry of the initial term or any subsequent term.

    The Strategic Partnership in detail
    HeraMED has signed a Strategic Partnership with Fond, a global SaaS platform that consolidates employee
    rewards and recognition processes into an easy-to-use solution. Fond was approached by one of their
    corporate customers requesting HeraCARE be added to the Fond platform as a way for them to provide
    improved maternity care for their employees and their family members. This initial Fond customer is a
    California-based, global social media company with over 7,000 employees and the program is scheduled to
    go live in the coming weeks. The HeraMED solution will be offered to all employees, and it will also be
    extended to their partners and up to five family members.

    The intention of this enterprise agreement is to allow Fond to add HeraCARE to all the employees of their
    corporate customers including partners and family members. Each Corporate client may choose to subsidise
    the cost of the HeraCARE solution in part or in full. Government funded reimbursements and tax deductions
    may also be available depending on the unique financial situation of the employee.

    In addition to the Fond enterprise agreement, HeraMED entered into an agreement with Entrustia Health, to
    provide Obstetrics and Gynaecology support to those pregnant women using HeraCARE through the Fond
    agreement. Entrustia Health’s obstetricians and clinicians will be responsible for coordinating the
    implementation and provision of care support.
 
watchlist Created with Sketch. Add HMD (ASX) to my watchlist
(20min delay)
Last
2.2¢
Change
-0.001(4.35%)
Mkt cap ! $17.32M
Open High Low Value Volume
2.2¢ 2.2¢ 2.2¢ $33.66K 1.53M

Buyers (Bids)

No. Vol. Price($)
3 1088930 2.2¢
 

Sellers (Offers)

Price($) Vol. No.
2.3¢ 58892 2
View Market Depth
Last trade - 10.07am 31/10/2024 (20 minute delay) ?
HMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.